You just read:

Mallinckrodt Completes Acquisition of InfaCare Pharmaceutical Corporation and Stannsoporfin, its Proprietary Therapy in Late-Stage Development for Newborns at Risk for Severe Jaundice

News provided by

Mallinckrodt plc

Sep 25, 2017, 17:00 ET